奇点网|双杀乳腺癌!HER2乳腺癌治疗跨入“双靶向时代”( 四 )


11.AgusDB,AkitaRW,FoxWD,etal.Targetingligand-activatedErbB2signalinginhibitsbreastandprostatetumorgrowth[J].CancerCell,2002,2(2):127-137.
12.AgusDB,GordonMS,TaylorC,etal.PhaseIclinicalstudyofpertuzumab,anovelHERdimerizationinhibitor,inpatientswithadvancedcancer[J].JournalofClinicalOncology,2005,23(11):2534-2543.
13.NahtaR,HungMC,EstevaFJ.TheHER-2-targetingantibodiestrastuzumabandpertuzumabsynergisticallyinhibitthesurvivalofbreastcancercells[J].CancerResearch,2004,64(7):2343-2346.
14.https://www.gene.com/stories/swinging-for-the-fences
15.https://www.gene.com/media/press-releases/8431/2005-05-15/data-from-omnitarg-clinical-program-pres
16.SwainSM,BaselgaJ,KimSB,etal.Pertuzumab,trastuzumab,anddocetaxelinHER2-positivemetastaticbreastcancer[J].NewEnglandJournalofMedicine,2015,372(8):724-734.
17.GingrasI,GebhartG,deAzambujaE,etal.HER2-positivebreastcancerislostintranslation:timeforpatient-centeredresearch[J].NatureReviewsClinicalOncology,2017,14(11):669.
【奇点网|双杀乳腺癌!HER2乳腺癌治疗跨入“双靶向时代”】头图来源:基因泰克


推荐阅读